Edwards Lifesciences:
|
|
| Date: |
Monday 9 October |
| Time: |
12:45-14:00 |
| Room: |
E1 |
|
|
THE NEW INSPIRIS RESILIA AORTIC VALVE: CURRENT EVIDENCE AND ITS EARLY CLINICAL APPLICATION
| Chairs: |
O. Wendler, King’s College Hospital, London, UK – A. Diegeler, Herz- und Gefäßklinik in Bad Neustadt, Germany |
| WHAT’S NEW ABOUT THE NEW EUROPEAN AND AMERICAN GUIDELINES? |
Anno Diegeler, Herz- und Gefäßklinik in Bad Neustadt, Germany |
| EPIDEMIOLOGY AND CURRENT TREATMENT OPTIONS IN YOUNGER PATIENTS |
Ruggero De Paulis, European Hospital, Rome Italy |
| RESILIA TISSUE: 2-YEAR CLINICAL SAFETY TRIALS UPDATE |
David Heimonsohn, St. Vincent Heart Center of Indiana, US |
| REAL-LIFE CLINICAL DECISION MAKING with INSPIRIS RESILIA |
Olaf Wendler, King’s College Hospital, London, UK |
Back to satellite list >>>
